Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Measuring the Burden of Infodemics: Summary of the Methods and Results of the Fifth WHO Infodemic Management Conference.
Wilhelm E, Ballalai I, Belanger ME, Benjamin P, Bertrand-Ferrandis C, Bezbaruah S, Briand S, Brooks I, Bruns R, Bucci LM, Calleja N, Chiou H, Devaria A, Dini L, D'Souza H, Dunn AG, Eichstaedt JC, Evers SMAA, Gobat N, Gissler M, Gonzales IC, Gruzd A, Hess S, Ishizumi A, John O, Joshi A, Kaluza B, Khamis N, Kosinska M, Kulkarni S, Lingri D, Ludolph R, Mackey T, Mandić-Rajčević S, Menczer F, Mudaliar V, Murthy S, Nazakat S, Nguyen T, Nilsen J, Pallari E, Pasternak Taschner N, Petelos E, Prinstein MJ, Roozenbeek J, Schneider A, Srinivasan V, Stevanović A, Strahwald B, Syed Abdul S, Varaidzo Machiri S, van der Linden S, Voegeli C, Wardle C, Wegwarth O, White BK, Willie E, Yau B, Purnat TD. Wilhelm E, et al. Among authors: ballalai i. JMIR Infodemiology. 2023 Feb 20;3:e44207. doi: 10.2196/44207. eCollection 2023. JMIR Infodemiology. 2023. PMID: 37012998 Free PMC article.
Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.
Pileggi GS, Da Mota LMH, Kakehasi AM, De Souza AW, Rocha A, de Melo AKG, da Fonte CAM, Bortoletto C, Brenol CV, Marques CDL, Zaltman C, Borba EF, Reis ER, Freire EAM, Klumb EM, Christopoulos GB, Laurindo IMM, Ballalai I, Da Costa IP, Michelin L, de Azevêdo Valadares LD, Chebli LA, Lacerda M, Toscano MAF, Yazbek MA, De Abreu Vieira RMR, Magalhães R, Kfouri R, Richtmann R, Merenlender SDCS, Valim V, De Assis MR, Kowalski SC, Trevisani VFM. Pileggi GS, et al. Among authors: ballalai i. Adv Rheumatol. 2019 Apr 29;59(1):17. doi: 10.1186/s42358-019-0056-x. Adv Rheumatol. 2019. PMID: 31036077